Breast-Specific Gamma Imaging: An Added Value in the Diagnosis of Breast Cancer, a Systematic Review

被引:3
|
作者
De Feo, Maria Silvia [1 ]
Sidrak, Marko Magdi Abdou [1 ]
Conte, Miriam [1 ]
Frantellizzi, Viviana [1 ]
Marongiu, Andrea [2 ]
De Cristofaro, Flaminia [1 ]
Nuvoli, Susanna [2 ]
Spanu, Angela [2 ]
De Vincentis, Giuseppe [1 ]
机构
[1] Sapienza Univ Rome, Dept Radiol Sci Oncol & Anatomopathol, I-00161 Rome, Italy
[2] Univ Sassari, Dept Med Surg & Expt Sci, Unit Nucl Med, I-07100 Sassari, Italy
关键词
breast specific gamma imaging; ultrasound; mammography; MRI; US; MRSI; BSGI and ultrasound; BSGI and MRI; BSGI and MMG; POSITRON EMISSION MAMMOGRAPHY; CARCINOMA-IN-SITU; NEOADJUVANT CHEMOTHERAPY; SCREENING MAMMOGRAPHY; HIGH-RISK; WOMEN; MRI; PERFORMANCE; MODALITY; BSGI;
D O I
10.3390/cancers14194619
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Breast-specific gamma imaging represents an emergent instrument for breast cancer detection. We selected on Medline articles published from 1995 to 2022 that compare various imaging modalities with breast-specific gamma imaging. The aim of this paper was to assess if this imaging method is a more valuable choice in detecting breast malignant lesions compared to morphological counterparts such mammography, ultrasound, and magnetic resonance imaging in terms of specificity, sensibility and positive and negative predictive value. At the cost of a major radiology burden, breast-specific gamma imaging is more specific, with a sensibility comparable to magnetic resonance imaging and higher than ultrasonography and mammography. Purpose: Breast cancer is the most common solid tumor and the second highest cause of death in the United States. Detection and diagnosis of breast tumors includes various imaging modalities, such as mammography (MMG), ultrasound (US), and contrast-enhancement MRI. Breast-specific gamma imaging (BSGI) is an emerging tool, whereas morphological imaging has the disadvantage of a higher absorbed dose. Our aim was to assess if this imaging method is a more valuable choice in detecting breast malignant lesions compared to morphological counterparts. Methods: research on Medline from 1995 to June 2022 was conducted. Studies that compared at least one anatomical imaging modality with BSGI were screened and assessed through QUADAS2 for risk of bias and applicability concerns assessment. Sensitivity, specificity, positive and negative predictive value (PPV and NPV) were reported. Results: A total of 15 studies compared BSGI with MMG, US, and MRI. BSGI sensitivity was similar to MRI, but specificity was higher. Specificity was always higher than MMG and US. BSGI had higher PPV and NPV. When used for the evaluation of a suspected breast lesion, the overall sensitivity was better than the examined overall sensitivity when BSGI was excluded. Risk of bias and applicability concerns domain showed mainly low risk of bias. Conclusion: BSGI is a valuable imaging modality with similar sensitivity to MRI but higher specificity, although at the cost of higher radiation burden.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Prognostic Value of Semiquantitative Tumor Uptake on Tc-99m Sestamibi Breast-Specific Gamma Imaging in Invasive Ductal Breast Cancer
    Jang, S.
    Yoon, H.
    Kim, Y.
    Kim, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S615 - S615
  • [42] Breast-specific gamma imaging of invasive breast cancer: Clinicopathologic factors affecting detectability and correlation with mammographic findings
    Park, Ji Yeon
    Chun, Kyung Ah
    Shin, Hyuk Jai
    Yi, Seong Yoon
    Kwon, Heon-Ju
    Park, Hee Jin
    CLINICAL IMAGING, 2018, 51 : 168 - 173
  • [43] Clinical utility of breast-specific gamma imaging for evaluating disease extent in the newly diagnosed breast cancer patient
    Zhou, Minhao
    Johnson, Nathalie
    Gruner, Sam
    Ecklund, G. W.
    Meunier, Paul
    Bryn, Sally
    Glissmeyer, Margie
    Steinbock, Kari
    AMERICAN JOURNAL OF SURGERY, 2009, 197 (02): : 159 - 163
  • [44] Correlation of tumor uptake on breast-specific gamma imaging and fluorodeoxyglucose PET/CT with molecular subtypes of breast cancer
    Lee, Soo Jin
    Chung, Min Sung
    Shin, Su-Jin
    Choi, Yun Young
    MEDICINE, 2018, 97 (43)
  • [45] Clinical Utility of Breast-Specific Gamma Imaging in Patients Receiving Neoadjuvant Chemotherapy: An Institutional Review
    Damle, Sameer
    McSwain, Anita P.
    Brem, Rachel F.
    Rapelyea, Jocelyn A.
    Torrente, Jessica
    Tatarian, Talar
    Teal, Christine B.
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (02) : S169 - S169
  • [46] Usefulness of feature analysis of breast-specific gamma imaging for predicting malignancy
    Eun Kyoung Choi
    Jooyeon Jamie Im
    Chang Suk Park
    Yong-An Chung
    Kijun Kim
    Jin Kyoung Oh
    European Radiology, 2018, 28 : 5195 - 5202
  • [47] Clinical use of a stereotactic breast-specific gamma imaging apparatus in the localization of breast lesions for biopsy
    Welch, B. L.
    Lorino, C.
    Chiarella, D.
    Hodge, T.
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (04) : 675 - 675
  • [48] Usefulness of feature analysis of breast-specific gamma imaging for predicting malignancy
    Choi, Eun Kyoung
    Im, Jooyeon Jamie
    Park, Chang Suk
    Chung, Yong-An
    Kim, Kijun
    Oh, Jin Kyoung
    EUROPEAN RADIOLOGY, 2018, 28 (12) : 5195 - 5202
  • [49] Diagnostic performance of breast-specific gamma imaging in the assessment of residual tumor after neoadjuvant chemotherapy in breast cancer patients
    Lee, Hyo Sang
    Ko, Beom Seok
    Ahn, Sei Hyun
    Son, Byung Ho
    Lee, Jong Won
    Kim, Hee Jeong
    Yu, Jong Han
    Kim, Sung-Bae
    Jung, Kyung Hae
    Ahn, Jin-Hee
    Cha, Joo Hee
    Kim, Hak Hee
    Lee, Hee Jin
    Song, In-Hye
    Gong, Gyungyub
    Park, Seol-Hoon
    Lee, Jong Jin
    Moon, Dae Hyuk
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 145 (01) : 91 - 100
  • [50] Molecular Breast Imaging: A multicenter clinical registry to compare breast-specific gamma imaging (BSGI) and breast MRI in the detection of breast carcinoma
    Weigert, J. M.
    Kieper, D. A.
    Stern, L. H.
    Bohm-Velez, M.
    CANCER RESEARCH, 2012, 72